| Value | ₹6.22 Cr |
|---|---|
| Execution period | upto 31st August, 2026 |
BSE filing, NSE: CHOICEIN. Summary written from the filing by ALFA Finder's alert engine.
Choice International Ltd: key numbers
- Share price
- ₹745.95
- Market cap
- ₹16,618 Cr
- Revenue (annual)
- ₹1,119 Cr
- Net profit (annual)
- ₹217.7 Cr
- P/E (TTM)
- 64.9×Sector 19.5×
- Promoter holding
- 53.65%+0.00% QoQ
- FII holding
- 9.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Choice International Ltd
All →Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr
Choice International Acquisition
Choice International acquired 100% stakes in Truestock Universe and Quanthm Bit Works for Rs.10,000 each, entering digital/technology space. Its material subsidiary CCSPL also sold its entire stake in SKP Green Ventures, making it a step-down subsidiary.
Choice International Earnings Call Transcript: Key Takeaways
Record consolidated revenue of ₹379 Cr (+33%) and PAT of ~₹70 Cr (+23%) at a 34.5% EBITDA margin. Growth was partly IPO-led, and regulatory and NBFC funding-cost risks were acknowledged but not quantified.
Choice International Results Update
Choice International reported record Q2 FY27 consolidated revenue of ₹379 crore, up 33% year-on-year. Net profit rose 23% to ₹69.47 crore.
Choice International Investor Presentation: Key Takeaways
Q2 FY27: Revenue ₹379 Cr (+33% YoY), EBITDA ₹131 Cr (+32%), PAT ₹69.5 Cr (+23%). Diversified broking, advisory, wealth, insurance and NBFC platform; ₹900 Cr NH Investment infusion received.
Choice International Bonus Issue
Choice International approved a 1:1 bonus issue, subject to shareholder approval. It also proposed increasing authorised capital and convening an EGM.
Other merger & restructuring announcements
All →Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr
HEG Advanced Materials Merger & Restructuring Worth ₹10.12 Cr
HEG Advanced Materials closed LNJ Trading FZCO, its Dubai-based wholly owned subsidiary, as part of overseas structure rationalisation. The filing quantifies the effect at AED 4,048,000.
- Value
- ₹10.12 Cr